Improving cancer therapy by non-genotoxic activation of p53

By Lain S.   Lane D.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1053-1060

Elsevier

Access to resources Recommend Favorite

p53 Targeting Can Enhance Cancer Therapy via Radiation, Heat and Anti-Cancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 5, 2008-06 ,pp. : 564-570

Bentham Science Publishers

Access to resources Recommend Favorite

Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway

By                

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 584-592

Spandidos Publications

Access to resources Recommend Favorite

Translational regulation of p53 as a potential tumor therapy target

By Schumacher Björn   Gartner Anton  

Future Oncology, Vol. 2, Iss. 1, 2006-02 ,pp. : 145-153

Future Medicine

Access to resources Recommend Favorite

Potential of Advexin^®®: a p53 gene-replacement therapy in Li––Fraumeni syndrome

By Nemunaitis Jackie M   Nemunaitis John  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 759-768

Future Medicine

Access to resources Recommend Favorite